| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis C Bombardier, L Laine, A Reicin, D Shapiro, R Burgos-Vargas, B Davis, ... New England Journal of Medicine 343 (21), 1520-1528, 2000 | 5413 | 2000 |
| The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection M Rudwaleit, D Van Der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, ... Annals of the rheumatic diseases 68 (6), 777-783, 2009 | 4477 | 2009 |
| The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis J Sieper, M Rudwaleit, X Baraliakos, J Brandt, J Braun, R Burgos-Vargas, ... Annals of the rheumatic diseases 68 (Suppl 2), ii1-ii44, 2009 | 2081 | 2009 |
| 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis J Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, ... Annals of the rheumatic diseases 70 (6), 896-904, 2011 | 1504 | 2011 |
| ASAS/EULAR recommendations for the management of ankylosing spondylitis J Zochling, D van der Heijde, R Burgos-Vargas, E Collantes, JC Davis, ... Annals of the rheumatic diseases 65 (4), 442-452, 2006 | 1107 | 2006 |
| Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis F De Benedetti, HI Brunner, N Ruperto, A Kenwright, S Wright, I Calvo, ... New England Journal of Medicine 367 (25), 2385-2395, 2012 | 951 | 2012 |
| Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS), ... Nature genetics 45 (7), 730-738, 2013 | 744 | 2013 |
| Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial N Ruperto, DJ Lovell, P Quartier, E Paz, N Rubio-Pérez, CA Silva, ... The Lancet 372 (9636), 383-391, 2008 | 654 | 2008 |
| The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of … JM Kremer, BJ Bloom, FC Breedveld, JH Coombs, MP Fletcher, D Gruben, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 630 | 2009 |
| Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force JS Smolen, J Braun, M Dougados, P Emery, O FitzGerald, P Helliwell, ... Annals of the rheumatic diseases 73 (1), 6-16, 2014 | 614 | 2014 |
| 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis D van der Heijde, J Sieper, WP Maksymowych, M Dougados, ... Annals of the rheumatic diseases 70 (6), 905-908, 2011 | 593 | 2011 |
| Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double‐blind treatment phase of a … JM Kremer, R Blanco, M Brzosko, R Burgos‐Vargas, AM Halland, ... Arthritis & Rheumatism 63 (3), 609-621, 2011 | 540 | 2011 |
| Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group RGW Lambert, PAC Bakker, D van der Heijde, U Weber, M Rudwaleit, ... Annals of the rheumatic diseases 75 (11), 1958-1963, 2016 | 511 | 2016 |
| A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard … N Ruperto, KJ Murray, V Gerloni, N Wulffraat, SK Feitosa De Oliveira, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 470 | 2004 |
| Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use L Laine, LG Connors, A Reicin, CJ Hawkey, R Burgos–Vargas, ... Gastroenterology 124 (2), 288-292, 2003 | 468 | 2003 |
| The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: results of a twelve‐month, multicenter, exploratory … JT Merrill, R Burgos‐Vargas, R Westhovens, A Chalmers, D D'cruz, ... Arthritis & Rheumatism 62 (10), 3077-3087, 2010 | 432 | 2010 |
| Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus A Martini, A Ravelli, T Avcin, MW Beresford, R Burgos-Vargas, R Cuttica, ... The Journal of rheumatology 46 (2), 190-197, 2019 | 429 | 2019 |
| Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology I Peláez-Ballestas, LH Sanin, J Moreno-Montoya, J Alvarez-Nemegyei, ... The Journal of Rheumatology Supplement 86, 3-8, 2011 | 413 | 2011 |
| Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve‐week, randomized, placebo‐controlled trial ME Weinblatt, A Kavanaugh, R Burgos‐Vargas, AH Dikranian, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 411 | 2008 |
| Efficacy and safety of abatacept in lupus nephritis: a twelve‐month, randomized, double‐blind study R Furie, K Nicholls, TT Cheng, F Houssiau, R Burgos‐Vargas, SL Chen, ... Arthritis & rheumatology 66 (2), 379-389, 2014 | 361 | 2014 |
Nicolino RupertoIRCCS Istituto G. Gaslini UOC Gaslini Trial Centre/Servizio di Sperimentazioni Cliniche PediatricheVerified email at gaslini.org
